IE
LPCN icon

Israel Englander’s Lipocine LPCN Stock Holding History

Israel Englander’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,855
Closed -$59K – 6451
2023
Q1 		$59K Buy
10,855
+7,217
+198% +$55.7K ﹤0.01% 5569
2022
Q4 		$24K Sell
3,638
-661
-15% -$4.82K ﹤0.01% 6001
2022
Q3 		$33K Sell
4,299
-7,470
-63% -$83.4K ﹤0.01% 6312
2022
Q2 		$160K Buy
+11,769
New +$183K ﹤0.01% 5738
2021
Q1 		– Sell
-1,459
Closed -$34K – 6265
2020
Q4 		$34K Buy
+1,459
New +$35.1K ﹤0.01% 5109
2020
Q3 		– Sell
-3,702
Closed -$79K – 4664
2020
Q2 		$79K Buy
3,702
+376
+11% +$4.87K ﹤0.01% 4007
2020
Q1 		$27K Buy
3,326
+334
+11% +$2.64K ﹤0.01% 3720
2019
Q4 		$20K Buy
2,992
+1,589
+113% +$40.7K ﹤0.01% 4126
2019
Q3 		$67K Buy
+1,403
New +$56.3K ﹤0.01% 4013
2018
Q1 		– Sell
-7,872
Closed -$460K – 3896
2017
Q4 		$460K Sell
7,872
-3,497
-31% -$217K ﹤0.01% 3135
2017
Q3 		$767K Buy
11,369
+112
+1% +$8.1K ﹤0.01% 2647
2017
Q2 		$769K Buy
11,257
+5,438
+93% +$355K ﹤0.01% 2585
2017
Q1 		$386K Sell
5,819
-5,193
-47% -$337K ﹤0.01% 2933
2016
Q4 		$689K Buy
+11,012
New +$697K ﹤0.01% 2475
2016
Q2 		– Sell
-1,903
Closed -$295K – 3399
2016
Q1 		$328K Buy
+1,903
New +$325K ﹤0.01% 2732
2015
Q4 		– Sell
-2,806
Closed -$564K – 3622
2015
Q3 		$564K Sell
2,806
-324
-10% -$75K ﹤0.01% 2596
2015
Q2 		$456K Buy
+3,130
New +$388K ﹤0.01% 2679
2015
Q1 		– Sell
-7,288
Closed -$652K – 3883
2014
Q4 		$652K Buy
7,288
+1,406
+24% +$119K ﹤0.01% 2809
2014
Q3 		$611K Buy
5,882
+5,188
+748% +$645K ﹤0.01% 2632
2014
Q2 		$72K Buy
+694
New +$83K ﹤0.01% 3282

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Israel Englander's LPCN Position: Q2 2023 in Review

Israel Englander sold out of Lipocine (LPCN) in Q2 2023, closing a stake of 10,855 shares — an estimated $59K sold.

Israel Englander first reported a position in LPCN in Q2 2014 and held it in 20 quarters. The position peaked at $769K in Q2 2017. 24 funds tracked by Wall St. Rank hold LPCN as of Q2 2023.

  • Israel Englander reported no remaining Lipocine position as of Q2 2023 after selling out during the quarter.
  • Israel Englander sold 10,855 Lipocine shares in Q2 2023, an estimated $59K.
  • Israel Englander first reported a position in Lipocine in Q2 2014 and held it in 20 quarters.
  • Israel Englander's Lipocine position peaked at $769K in Q2 2017.
  • 24 funds tracked by Wall St. Rank held Lipocine as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.